MATTHEW PERRONE
AP Health Writer

WASHINGTON (AP) – Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies.
North Chicago-based Abbott acquired the unit as part of its $6.2 billion purchase of Belgium-based Solvay Pharmaceuticals in February.
"We explored the option to potentially sell the business and determined it was in the best interest of Abbott and the vaccines business to retain it and integrate it into the company," said Abbott spokesman Scott Stoffell.
Source